Xu, S; Gaskin, F (1997) Increased incidence of anti-beta-amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease. Mech Ageing Dev 94:213-22
|
Fang, Q; Kannapell, C C; Fu, S M et al. (1995) VH and VL gene usage by anti-beta-amyloid autoantibodies in Alzheimer's disease: detection of highly mutated V regions in both heavy and light chains. Clin Immunol Immunopathol 75:159-67
|
Fang, Q; Kannapell, C C; Gaskin, F et al. (1994) Human rheumatoid factors with restrictive specificity for rabbit immunoglobulin G: auto- and multi-reactivity, diverse VH gene segment usage and preferential usage of V lambda IIIb. J Exp Med 179:1445-56
|
Gaskin, F; Finley, J; Fang, Q et al. (1993) Human antibodies reactive with beta-amyloid protein in Alzheimer's disease. J Exp Med 177:1181-6
|
Gaskin, F; Fu, S M (1992) Antineurofibrillary tangle, antineural and anti-beta-amyloid-protein in Alzheimer's disease and related disorders. Res Immunol 143:668-70
|
Kingsley, B S; Gaskin, F; Fu, S M (1988) Human antibodies to neurofibrillary tangles and astrocytes in Alzheimer's disease. J Neuroimmunol 19:89-99
|
Gaskin, F; Kingsley, B S; Fu, S M (1987) Autoantibodies to neurofibrillary tangles and brain tissue in Alzheimer's disease. Establishment of Epstein-Barr virus-transformed antibody-producing cell lines. J Exp Med 165:245-50
|